ABCD is proud to announce the formal election of Dr Garry Tan, Oxford University Hospitals NHS Foundation Trust, as our representative on the Joint Specialist Committee for Endocrinology & Diabetes (JSC) at the Royal College of Physicians (RCP)

JSC brings together representatives of the RCP, ABCD, Society for Endocrinology (SfE)  and Diabetes UK formally twice a year, in addition to electronic online work, to share information and facilitate collaboration.

Chairing of the JSC is alternated between ABCD and SfE.

Well done Garry!

2021 Update

This guidance is for a variety of clinicians who treat people with diabetic kidney disease, including primary care physicians and specialists in diabetes, cardiology and nephrology. It intends to harmonise practices of blood pressure monitoring, and pharmacological and non-pharmacological management of hypertension, which vary considerably in different settings.

Updated 2021

The primary purpose of these guidelines is to provide practical recommendations on lipid management for diabetologists, nephrologists, general practitioners and other members of the multidisciplinary team involved in the care of adults with diabetic kidney disease (DKD).  

2021 Update

This guidance is for the variety of clinicians who treat people with diabetic kidney disease, including GPs and specialists in diabetes, cardiology and nephrology. It intends to harmonise practices of blood glucose monitoring, and pharmacological and non-pharmacological management of hyperglycaemia, which may vary considerably. 

ABCD and Renal Association have produced guidelines on the detection and management of diabetes post solid organ transplantation as well as a summary document of the recommendations. 

Published in Diabetic Medicine in 2021, DOI: 10.111/dme.14523

In this second of a series of three webinars focussing on obesity, hosted by ABCD and GIRFT and supported by Novo Nordisk Ltd, Professor Barbara McGowan will present an update on current and future obesity services in the UK, and Susannah Howard will talk about the commissioning perspective.

ABCD would like to announce these two QI opportunities from the NDA team for diabetes services and CCG/Healthboards to our members. Please note the tight deadline of 21st April 2021.

Effect of empagliflozin on albuminuria, eGFR and serum creatinine: updated results from the ABCD national empagliflozin audit. Thomas SJ Crabtree¹, Alex Bickerton², Jackie Elliot³, Rajeev Raghavan⁴, Dennis Barnes⁵, Siva Sivappriyan⁶, Suzanne Phillips⁷, Alison Evans⁷, Devesh Sennik⁸, Anurita Rohilla⁹, Ian Gallen¹⁰, Robert EJ Ryder¹¹ on behalf of the  ABCD Empagliflozin Audit Contributors. British Journal of Diabetes Vol 21 14/04/2021

Due to the pressure on hospital teams during the COVID pandemic, we have postponed the 2021 competition but are launching a revamped award for 2022 which has been amended to take into account the current COVID situation. We are inviting colleagues to submit entries which will be for:

‘The Rowan Hillson Inpatient Safety Award – The best interventions: Redesigning, rebuilding and maintaining safe inpatient diabetes care during COVID’